| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5104903 | Value in Health | 2016 | 7 Pages |
Abstract
The synergistic aspects of MBMA and pharmacoeconomic modeling are highlighted in this hypothetical example. Markov microsimulation modeling allows the finer predictions of MBMA to inform parameters. Such an approach has utility in both early-phase cost-effectiveness estimations and trial design.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Julia F. PhD, Richard J. PhD, Jakob PhD, Peter PhD,